Noviga Research

Keiretsu Forum NordicsPortfolio

Noviga Research is a Swedish Pharma/Biotech Company focused on the development of novel medicines for the treatment of diseases with high unmet medical need, such as cancer. The company is based at the Biovation Park (former AstraZeneca R&D facility) in Södertälje, Sweden. Noviga develops small-molecule patented drugs that can extend patient life, our lead anti-cancer compound NOV202 is close to entering GLP-tox and safety studies, followed by a Phase Ib/IIa clinical trial in patients with relapsing and/or treatment refractory cancer.